| Start: | $485.00 |
| Current: | $485.00 (0.00%) |
| Target: | $495.00 (2.06%) in 30 days |
Google has only scratched the surface of its social networking capabilities. Google's knol will become a familiar term over the next few months; and from what we've seen in the past, they're going to take every advantage of this new realm.
| Start: | $39.83 |
| Current: | $39.83 (0.00%) |
| Target: | $65.00 (63.19%) in 183 days |
and to collect a good dividend while you wait for the stock price to go up (do I hear winter?) Seems like an excellent stock to trade the channels. Buy now (August) while NG price is low and the yield is high (near 10%) Sell when the NG price peaks, collect the stock appreciation and the dividends and wait for the NG price to erode into the summer. Better than bonds. No company debt. Recommended by Dennis Gartman today (8/20) also.
| Start: | $4.49 |
| Current: | $4.40 (-2.00%) |
| Target: | $0.01 (-99.78%) in 30 days |
Look can we all just come together and accept that Fannie Mae is heading down to near 0? We all know its going to happen
| Start: | $64.56 |
| Current: | $64.58 (0.03%) |
| Target: | $80.00 (23.92%) in 91 days |
Eni SpA, NYSE symbol E, is an integrated energy company having operations involving oil, gas, electricity, petrochemicals, and engineering. The company, which is headquartered in Rome, Italy, currently has operations in Italy, the United Kingdom, Norway, Libya, Egypt, Angola, Nigeria, Congo, the United States, Kazakhstan, Russia, and Australia. One part of the company is involved with the exploration of oil and natural gas which is becoming more important as world demand increases and the price of oil continues to rise. Eni SpA also supplies, transports, distributes, and markets natural gas and produces electricity. Another division refines and markets petroleum products and runs retail fuel stations. Eni SpA's petrochemical products include olefins and aromatics which are involved with producing diesel fuel from vegetable oil. Another part of Eni SpA, which may become important to the United States and the offshore drilling
... More| Start: | $17.77 |
| Current: | $17.96 (1.07%) |
| Target: | $20.00 (12.55%) in 30 days |
I think we all know that lunista is not showing the best growth out of all of the sleeping drugs but i feel that the respiratory drugs which sepracor is now highlighting will show stronger than expected sales. Bottom line, don't buy this stock for lunista buy it for the lesser known drugs.